About this Journal Submit a Manuscript Table of Contents

Ocular Trauma

Call for Papers

United States Eye Injury Registry reports that eye injury is the leading cause of monocular blindness in the US. It estimates that a half-a-million year of lost eyesight occurs annually in the US due to trauma. It is most prevalent in working age individuals; it leads to an immense economic and societal burden. Visual prognosis in open globe injuries, especially the penetrating injuries, is poor. Prompt diagnosis and treatment by an experienced ocular trauma team may be the best management course to attain the best visual outcome. Recent improvements in surgical technology may be helpful in managing the complex trauma-related complications. Over 90% of all ocular injuries may be preventable. Of all the eye injuries reported in eye injury snapshot study, fewer than 5% were wearing protective eyewear.

The main focus of the special issue is the recent management strategies in the treatment of complications of ocular trauma. We invite authors to submit original articles, review articles, and clinical studies. Potential topics include, but are not limited to:

  • Eyelid and canalicular lacerations
  • Chemical ocular injuries
  • Traumatic cataract
  • Blunt ocular trauma
  • Penetrating ocular injuries
  • Intraocular foreign bodies
  • Traumatic endophthalmitis
  • Antibiotic prophylaxis in open globe injuries
  • Orbital fractures
  • Traumatic optic nerve injury

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/joph/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/joph/otr/ according to the following timetable:

Manuscript DueFriday, 14 February 2014
First Round of ReviewsFriday, 9 May 2014
Publication DateFriday, 4 July 2014

Lead Guest Editor

  • Neelakshi Bhagat, Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School, 90 Bergen Street, Newark, NJ 07103, USA

Guest Editors

  • Marco Zarbin, Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School, 90 Bergen Street, Newark, NJ 07103, USA
  • Paul Langer, Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School, 90 Bergen Street, Newark, NJ 07103, USA
  • Samuel Yiu, Division of Cornea, Cataract & External Diseases, The Wilmer Eye Institute, The Johns Hopkins Medical School, Baltimore, MD, USA